25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with chronic kidney disease;Niveles de 25 hidroxivitamina D y riesgo cardiovascular en una cohorte de pacientes con enfermedad renal crónica avanzada

Nefrologia

Volumn 30, Issue 4, 2010, Pages 435-442

  Garcia Canton C ^a   Bosch, E ^a   Auyanet, I ^a   Ramirez A ^a   Rossique, P ^a   Culebras, C ^a   Sanchez A ^a   Toledo, A ^a   Lago, M ^a   Esparza, N ^a   Checa, M D ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Cardiovascular disease; Chronic kidney disease; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN D; YOUNG ADULT;

EID: 77955999100     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Mar.10288     Document Type: Article

References (43)

1. Holick MF. Vitamin D deficency. N Engl J Med 2007;357:266-81.[Pubmed]
2. Maalouf NM. The noncalciotropic actions of vitamin D: recent clinica developments. Curr Opin Nephrol Hypertens 2008;17:408-15.[Pubmed]
3. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the Risk of Mortality in the General Population. Arch Intern Med 2008;168:1629-37.[Pubmed]
4. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhost U, Wllnitz B, et al. Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality. Arch Intern Med 2008;168:1340-9.[Pubmed]
5. Zittermann A, Gummert JF, Börgermann JB. Vitamin D deficiency and mortality. Curr Opin Clinl Nutr Metab Care 2009;12:634-9.
6. Giovannucci E. Vitamin D and cardiovascular disease. Curr Atheroscler Rep 2009;11:456-61.[Pubmed]
7. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arteria hypertension: a systematic review. Nat Rev Cardiol 2009;6:621-30.[Pubmed]
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, Chronic Kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 2004;351:1296-305.[Pubmed]
9. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-18.[Pubmed]
10. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK Association of elevated serum PO4, Ca x PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12:2131-8.[Pubmed]
11. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et al Vitamin D levels and early mortality among incedent hemodialysis patients. Kidney Int 2007;72:1004-13.[Pubmed]
12. Mehrotra R, Kermah D, Salusky IB, Wolg MS, Thadhani RI, Chiu YW, et al. Chronic kidney disease, hypovitaminosis D and mortality in the United States. Kidney Int 2009;76:977-83.[Pubmed]
13. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003;42(Suppl 3):1-202
14. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization M-mode echocardiographic eft ventricular anatomic measurements. J Am Coll Cardio 1984;4:1222-30.[Pubmed]
15. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or abscense of asynergy Am J Cardiol 1976;37:7-11.[Pubmed]
16. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005;45:1026-33.[Pubmed]
17. Gonzalez E, Sachdeva A, Oliver D, Martin K. Vitamin D insufficiency and Deficiency in Chronic Kidney Disease. Am J Nephro 2004;24:503-10.[Pubmed]
18. Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, Nuttall S, et al. Cross-sectional analysis of abnormalities of minera homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract 2007;107:c109-c116.[Pubmed]
19. Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009;32:1977-9.[Pubmed]
20. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis Osteoporos Int 2009;20:133-40.[Pubmed]
21. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005;62:265-81.[Pubmed]
22. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4-8.[Pubmed]
23. Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J, et al. Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls Obes Surg 2008;18:145-50.[Pubmed]
24. Al-Elq AH, Sadat-Ali M, Al-Turki HA, Al-Mulhim FA, Al-Ali AK. Is there a relationship between body mass index and serum vitamin D level. Saudi Med J 2009;30:1542-6.[Pubmed]
25. Winters SJ, Chennubhatla R, Wang C, Miller JJ. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 2009;58:438-42.[Pubmed]
26. Mucsi I, Almasi C, Déak G, Marton A, Ambrus C, Berta K, et al. Serum 25(OH) vitamin D levels and bone metabolism in patients on maintenance hemodialysis. Clin Nephro 2005;64:s288-s294
27. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WG, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-9.[Pubmed]
28. Almirall J, Vaqueiro M, Baré ML, Antón E. Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol Dial Transplant 2010;25:503-9.[Pubmed]
29. Matías PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in hemodialysis patients. Nephrol Dial Transplant 2009;24:611-8.[Pubmed]
30. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, et al. Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency. J Am Soc Nephrol 2007;18:613-20.[Pubmed]
31. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arteria Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease. Hypertension 2001;38:938-42.[Pubmed]
32. Klassen PS, Lowrie EG, Reddan DN, DeLong DR, Coladonato JA, Szczech LA, et al. Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis. JAMA 2002;287:1548-55.[Pubmed]
33. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third Nationa Health and Nutrition Examination Survey. Arch Intern Med 2007;167:1159-65.[Pubmed]
34. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease Circulation 2008;117:503-11.[Pubmed]
35. Wang AW, Lam CW, Sanderson JE, Wang M, Chang IH, Lui SF, et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin. Nutr 2008;87:1631-8
36. Adorini MC. The coming of age of 1,25-dihydroxyvitamin D analogs as immunomodulatory agents. Trends Mol Med 2002;8:174-9.[Pubmed]
37. Pai AB. Oxidative stress and inflammation in chronic kidney disease role of intravenous iron and vitamin D. J Phar Pract 2008;21:214-24
38. Cachofeiro V, Goicochea M, García de Vinuesa S, Oubia P, Lahera V Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int 2008;74:s4-s9
39. Li YC, Kong J, Wei M, Chen Z, Liu SQ, Cao L. 1,25-dihydroxyvitamin D3 is a negative endocrine regulator of the reninangiotensin system. J Clin Invest 2002;110:229-38.[Pubmed]
40. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2007;103:416-9.[Pubmed]
41. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002;40:1202-10.[Pubmed]
42. Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 1994;41:290-6.[Pubmed]
43. Koening KG, Lindberg JS, Zerwekh JE, Padalino PK, Cushner HM, Copley JB. Free and total 1.25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 1992;41:161-5.[Pubmed]